ASAP Wound Dressing Gel approved by FDA

SALT LAKE CITY American Biotech Labs on Tuesday announced that the company has been granted formal approval by the Food and Drug Administration to market its ASAP Wound Dressing Gel throughout the United States.

ASAP Wound Dressing Gel is indicated “for the topical management of minor cuts, lacerations, abrasions, first and second degree burns and skin irritations,” the company stated. The product utilizes ABL’s SilverSol Technology.

“We are delighted with the FDA’s decision to grant approval for ABL to broadly market our ASAP Wound Dressing Gel,” stated William Moeller, a managing director of American Biotech Labs. “We feel this is a singularly effective wound care product, and it is a tremendous validation for us that ABL products have now received approval from the FDA.”

ABL has performed extensive anti-microbial studies against bacteria, yeast, fungus and other pathogens. Information about these studies is available at the research section of the ABL Web site, www.americanbiotechlabs.com/researchprotected/researchmenu.html.